BIOTAGE AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 169.3 SEK | -0.41% |
|
+1.01% | +26.63% |
| Apr. 25 | Transcript : Biotage AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
| Apr. 25 | Biotage AB Approves a Dividend, Payable on May 3, 2024 | CI |
Presentation Operator MessageOperator (Operator)Welcome to Biotage Q1 2024 Report Presentation...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotageâs offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Companyâs offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.
Calendar
2024-07-15
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
169.3
SEK
Average target price
186.7
SEK
Spread / Average Target
+10.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +26.63% | 1.26B | |
| -15.34% | 18.88B | |
| -41.10% | 2.84B | |
| +24.02% | 1.85B | |
| +8.62% | 1.66B | |
| -7.74% | 989M | |
| -18.61% | 896M | |
| -1.03% | 757M | |
| -23.76% | 637M | |
| +7.08% | 500M |
- Stock Market
- Equities
- BIOT Stock
- News Biotage AB
- Transcript : Biotage AB, Q1 2024 Earnings Call, Apr 25, 2024